2B77:XETRA:XETRA-iShares Ageing Population UCITS Acc (EUR)

ETF | Others |

Last Closing

USD 7.57

Change

+0.08 (+1.05)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.18 (+0.35%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.41%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.19 (+0.66%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.44%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.11 (+0.42%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.58%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+1.92 (+1.38%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.19 (+0.36%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.92 (+0.86%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+5.98 (+0.98%)

USD 80.38B

ETFs Containing 2B77:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.76% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.76% 83% B 79% B-
Trailing 12 Months  
Capital Gain 21.26% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.26% 67% D+ 68% D+
Trailing 5 Years  
Capital Gain 30.45% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.45% 54% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 8.59% 59% D- 59% D-
Dividend Return 8.59% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.73% 32% F 44% F
Risk Adjusted Return 54.60% 47% F 53% F
Market Capitalization 0.50B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.